Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - magnesium sulfate heptahydrate, quantity: 500 mg/ml - injection, concentrated - excipient ingredients: water for injections - parenteral administration of magnesium is indicated in the treatment of acute hypomagnesaemia. magnesium salts are also indicated to prevent hypomagnesaemia in patients receiving total parenteral nutrition. magnesium sulphate is also indicated in the prevention and treatment of life-threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia). for emegency treatment of some arrhythmias such as torsade de pointes and those associated with hypokalemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - acetazolamide sodium, quantity: 549.5 mg (equivalent: acetazolamide, qty 500 mg) - injection, powder for - excipient ingredients: sodium hydroxide; hydrochloric acid - for adjunctive treatment of: oedema due to congestive heart failure; drug induced oedema; centrencephalic epilepsies (petit mal, unlocalised seizures); chronic simple (open-angle) glaucoma, secondary glaucoma and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - calcium chloride dihydrate, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - parental administration of calcium is indicated in the treatment of hypocalcaemia where rapid increase in plasma calcium is required, such as in hypocalcaemic tetany and tetany due to parathyroid deficiency. intravenous calcium is also indicated to antagonise the cardiotoxicity of hyperkalaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - vitamin a, quantity: 50000 iu - capsule, soft - excipient ingredients: allura red ac; caramel; soya oil; vanillin; gelatin; purified water; propyl hydroxybenzoate; glycerol; methyl hydroxybenzoate - oral treatment of chronic infections, dermatitis, acne, skin ulcers and eye lesions, when due to vitamin a deficiency; premenstrual tension; for prophylaxis against respiratory infections.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium bicarbonate, quantity: 84 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - activated charcoal, quantity: 0.2 g/ml - suspension - excipient ingredients: propylene glycol; glycerol; sucrose; citric acid; purified water; sodium hydroxide - for the treatment of poisoning and drug overdosage by oral ingestion.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - activated charcoal, quantity: 40 mg/ml - injection, suspension - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - aid to the stereotactic or ultrasonic localising of small lesions of the breast for later surgical excision.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium bicarbonate, quantity: 84 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 01 jan 1991 : prophylaxis of heat prostration or muscle cramps, chloride deficiency due to diuresis or salt restriction, prevention or treatment of extracellular volume depletion. parenteral - 0.9% (isotonic) nacl is used to restore sodium and chloride losses; to dilute or dissolve drugs for iv, im or sc use, flushing of iv catheters; extracellular fluid replacement; priming solution for hemodialysis; initiate and terminate blood transfusions so red blood cells will not hemolyze; metabolic alkalosis when there is fluid loss and mild sodium depletion. topical or irrigation - relief of inflamed, dry or crusted nasal membranes or as a topical irrigating or flush solution.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - activated charcoal, quantity: 0.2 g/ml; sorbitol, quantity: 0.283 g/ml - suspension - excipient ingredients: propylene glycol; citric acid; sodium hydroxide; glycerol; purified water - for the treatment of poisoning and drug overdosage by oral ingestion.